Renal Failure and Leukocytosis Are Predictors of a Complicated Course of Clostridium difficile Infection if Measured on Day of Diagnosis

被引:66
作者
Bauer, Marlijn P.
Hensgens, Marjolein P. M.
Miller, Mark A. [2 ]
Gerding, Dale N. [3 ,4 ]
Wilcox, Mark H. [5 ,6 ]
Dale, Adam P. [5 ]
Fawley, Warren N. [5 ]
Kuijper, Ed J. [1 ]
Gorbach, Sherwood L. [7 ,8 ]
机构
[1] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands
[2] McGill Univ, Jewish Gen Hosp, Div Infect Dis, Montreal, PQ H3T 1E2, Canada
[3] Vet Affairs Edward Hines Jr Hosp, Maywood, IL USA
[4] Loyola Univ, Chicago Sch Med, Maywood, IL 60153 USA
[5] Univ Leeds, Gen Infirm, Dept Microbiol, Old Med Sch, Leeds LS2 9JT, W Yorkshire, England
[6] Univ Leeds, Leeds Inst Mol Med, Leeds LS2 9JT, W Yorkshire, England
[7] Tufts Univ, Sch Med, Boston, MA 02111 USA
[8] Optimer Pharmaceut Inc, San Diego, CA USA
关键词
RISK-FACTORS; COLITIS; EPIDEMIOLOGY; SEVERITY; RELAPSE; SOCIETY; DISEASE;
D O I
10.1093/cid/cis340
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nonsevere Clostridium difficile infection (CDI) and severe CDI, which carries a higher risk than nonsevere CDI for treatment failure and CDI recurrence, are difficult to distinguish at the time of diagnosis. To investigate the prognostic value of 3 markers of severe CDI suggested by recent guidelines (fever, leukocytosis, and renal failure), we used the database of 2 randomized controlled trials, which contained information for 1105 patients with CDI. Leukocytosis (risk ratio [RR], 2.29; 95% confidence interval [CI], 1.63-3.21) and renal failure (RR, 2.52; 95% CI, 1.82-3.50) were associated with treatment failure. Fever, although associated with treatment failure (RR, 2.45; 95% CI, 1.07-5.61), was rare. Renal failure was the only significant predictor of recurrence (RR, 1.45; 95% CI, 1.05-2.02). Different timing of measurements of leukocyte count and serum creatinine level around the CDI diagnosis led to a different severity classification in many cases. In conclusion, both leukocytosis and renal failure are useful predictors, although timing of measurement is important.
引用
收藏
页码:S149 / S153
页数:5
相关论文
共 14 条
  • [1] European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)
    Bauer, M. P.
    Kuijper, E. J.
    van Dissel, J. T.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (12) : 1067 - 1079
  • [2] Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system
    Belmares, Jaime
    Gerding, Dale N.
    Parada, Jorge P.
    Miskevics, Scott
    Weaver, Frances
    Johnson, Stuart
    [J]. JOURNAL OF INFECTION, 2007, 55 (06) : 495 - 501
  • [3] Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
    Cohen, Stuart H.
    Gerding, Dale N.
    Johnson, Stuart
    Kelly, Ciaran P.
    Loo, Vivian G.
    McDonald, L. Clifford
    Pepin, Jacques
    Wilcox, Mark H.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) : 431 - 455
  • [4] Crook D, 2010, INF DIS SOC AM 48 AN
  • [5] Comparison of Clinical Severity Score Indices for Clostridium difficile Infection
    Fujitani, Shigeki
    George, W. Lance
    Murthy, A. Rekha
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2011, 32 (03) : 220 - 228
  • [6] Clinical Risk Factors for Severe Clostridium difficile-associated Disease
    Henrich, Timothy J.
    Krakower, Douglas
    Bitton, Asaf
    Yokoe, Deborah S.
    [J]. EMERGING INFECTIOUS DISEASES, 2009, 15 (03) : 415 - 422
  • [7] Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection
    Hu, Mary Y.
    Katchar, Kianoosh
    Kyne, Lorraine
    Maroo, Seema
    Tummala, Sanjeev
    Dreisbach, Valley
    Xu, Hua
    Leffler, Daniel A.
    Kelly, Ciaran P.
    [J]. GASTROENTEROLOGY, 2009, 136 (04) : 1206 - 1214
  • [8] A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C-difficile-associated disease in Quebec
    Hubert, Bruno
    Loo, Vivian G.
    Bourgault, Anne-Marie
    Poirier, Louise
    Dascal, Andre
    Fortin, Elise
    Dionne, Marc
    Lorange, Manon
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) : 238 - 244
  • [9] Fidaxomicin versus Vancomycin for Clostridium difficile Infection
    Louie, Thomas J.
    Miller, Mark A.
    Mullane, Kathleen M.
    Weiss, Karl
    Lentnek, Arnold
    Golan, Yoav
    Gorbach, Sherwood
    Sears, Pamela
    Shue, Youe-Kong
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05) : 422 - 431
  • [10] Health Care-Associated Clostridium difficile Infection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality
    Miller, Mark
    Gravel, Denise
    Mulvey, Michael
    Taylor, Geoffrey
    Boyd, David
    Simor, Andrew
    Gardam, Michael
    McGeer, Allison
    Hutchinson, James
    Moore, Dorothy
    Kelly, Sharon
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (02) : 194 - 201